Pharma

Eris Lifesciences Ltd

ERIS · NSE · INE406M01024
——consolidatedstandalone
Sentiment14 · Extreme Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E24.4
P/B4.0
EPS₹46.96
Div Yield1.3%
ROE19.2%
ROCE12.7%
ROE19.2%
1Y Return-22.58%
Avg. Volume0.1M

Price Chart

1,7021,5621,4231,2831,14419.2L38.4LOct 2025Nov 2025Dec 2025Feb 2026Mar 2026Apr 2026May 2026Jul 2026Aug 2026

About

Eris Lifesciences Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price—
52W High / Low—
Stock P/E24.4
Price to Book4.0
EPS (TTM)₹46.96
Dividend Yield1.3%
ROE19.2%
1Y Return-22.58%
Day Change—

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹3,230 Cr₹3,129 Cr₹2,894 Cr
Expenses₹2,092 Cr₹2,009 Cr₹1,876 Cr
Operating Profit₹1,138 Cr₹1,120 Cr₹1,018 Cr
OPM %35.0%36.0%35.0%
Other Income₹-9 Cr₹-9 Cr₹18 Cr
Depreciation₹281 Cr₹280 Cr₹315 Cr
Interest₹191 Cr₹193 Cr₹231 Cr
Profit Before Tax₹657 Cr₹639 Cr₹489 Cr
Tax₹-9 Cr₹-9 Cr₹114 Cr
Net Profit₹666 Cr₹648 Cr₹375 Cr
EPS (₹)46.844.725.8
Dividend Payout %—16%28%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹873 Cr₹757 Cr₹807 Cr₹792 Cr
Expenses₹577 Cr₹484 Cr₹526 Cr₹504 Cr
Operating Profit₹296 Cr₹272 Cr₹282 Cr₹288 Cr
OPM %34.0%36.0%35.0%36.0%
Depreciation₹72 Cr₹70 Cr₹70 Cr₹69 Cr
Interest₹47 Cr₹46 Cr₹49 Cr₹50 Cr
Net Profit₹143 Cr₹279 Cr₹109 Cr₹134 Cr
EPS (₹)10.320.37.38.8
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹14 Cr₹14 Cr₹14 Cr
Reserves₹3,889 Cr₹2,841 Cr₹2,573 Cr
Borrowings₹2,359 Cr₹2,478 Cr₹2,781 Cr
Other Liabilities₹861 Cr₹1,414 Cr₹1,366 Cr
Total Liabilities₹7,123 Cr₹6,747 Cr₹6,734 Cr
Assets
Fixed Assets₹5,188 Cr₹5,306 Cr₹4,319 Cr
Investments₹62 Cr₹67 Cr₹16 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹1,702 Cr₹1,307 Cr₹2,379 Cr
Total Assets₹7,123 Cr₹6,747 Cr₹6,734 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹538 Cr₹-369 Cr₹-314 Cr₹-145 Cr
FY25₹1,065 Cr₹-78 Cr₹-881 Cr₹105 Cr
FY24₹486 Cr₹-1,828 Cr₹1,380 Cr₹38 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd₹353 Cr75.3+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-21Appointment Of Mr. Akhil Awasthi As An Additional Director (Non-Executive, Independent) Of The CompanyBSE Filing2026-07-29Eris Lifesciences Ltd (NSE:ERIS) Q1 2027 Earnings Call Highlights: Strong Revenue Growth Amid ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.